InvestorsHub Logo
Followers 43
Posts 2488
Boards Moderated 0
Alias Born 10/19/2015

Re: Jonjones325 post# 384725

Tuesday, 11/22/2022 3:19:43 PM

Tuesday, November 22, 2022 3:19:43 PM

Post# of 461938
I don't expect there will be much fanfare at CTAD. Certainly not to the level many here are predicting. I get it. As investors, this is an exciting make-or-break moment that we've waited years to happen. But for most attendees, Anavex is just one of many interesting presentations that they'll attend. And while Sigma-1 may get some more credibility on 12/1, I don't think it's going to be an "earth is round" moment that causes everyone to rush to hear what Dr. Missling is presenting to the point where other presenters are left with an empty audience.

As for the stock price, a positive PR may cause a 10-20% pop and more importantly should create a new price floor even if it fills the gap. The long-term share price many want to see is still a few years away, after Blarcamesine has been approved and is generating substantial revenue and is a household name to those who suffer from CNS disease.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News